These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5073257)

  • 1. On estimating relative potency from quadratic log-dose response relationships.
    Cox CP
    Biometrics; 1972 Sep; 28(3):875-81. PubMed ID: 5073257
    [No Abstract]   [Full Text] [Related]  

  • 2. On biological assays involving quantal responses.
    Waud DR
    J Pharmacol Exp Ther; 1972 Dec; 183(3):577-607. PubMed ID: 4636393
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimating relative potency using prior information.
    Kim PT; Carter EM; Hubert JJ
    Biometrics; 1991 Mar; 47(1):295-301. PubMed ID: 2049503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining multivariate bioassays.
    Meisner M; Kushner HB; Laska EM
    Biometrics; 1986 Jun; 42(2):421-7. PubMed ID: 3741980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estimation of relative potency from two parabolas in symmetric bioassays.
    Williams DA
    Biometrics; 1973 Dec; 29(4):695-700. PubMed ID: 4785234
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioimmunoassay of gonadotrophins. I. Theoretical considerations.
    Petrusz P; Diczfalusy E; Finney DJ
    Acta Endocrinol (Copenh); 1971 May; 67(1):40-6. PubMed ID: 5108346
    [No Abstract]   [Full Text] [Related]  

  • 7. Multivariate bioassay.
    Vølund A
    Biometrics; 1980 Jun; 36(2):225-36. PubMed ID: 6996751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models for complex contingency tables and polychotomous dosage response curves.
    Mantel N
    Biometrics; 1966 Mar; 22(1):83-95. PubMed ID: 5954728
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-response models with covariates.
    Wijesinha MC; Piantadosi S
    Biometrics; 1995 Sep; 51(3):977-87. PubMed ID: 7548713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the biological assay of Herba Leonuri--analysis the dosage response curve of Herba Leonuri and oxytocin and establishment of adequate potency pattern].
    Yang M; Yang S; Jin Z; Zhu S
    Zhong Yao Cai; 2002 Jun; 25(6):409-11. PubMed ID: 12583332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some distribution-free properties of the asymptotic variance of the Spearman estimator in bioassays.
    Chang PC; Johnson EA
    Biometrics; 1972 Sep; 28(3):882-9. PubMed ID: 5073258
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parabola bioassays in the comparison of drug effects (author's transl)].
    Xu DZ
    Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):73-8. PubMed ID: 6461216
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.
    Singh GJ; Adams WP; Lesko LJ; Shah VP; Molzon JA; Williams RL; Pershing LK
    Clin Pharmacol Ther; 1999 Oct; 66(4):346-57. PubMed ID: 10546918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency.
    Ryan CA; Chaney JG; Gerberick GF; Kern PS; Dearman RJ; Kimber I; Basketter DA
    Cutan Ocul Toxicol; 2007; 26(2):135-45. PubMed ID: 17612980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay from two parabolas.
    Moussa MA
    Comput Biol Med; 1993 Jan; 23(1):69-76. PubMed ID: 8467640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of concentration -- time -- effect of benzol inhalation on the body in acute and subacute experiment].
    Pavlov VN; Avaliani SL
    Gig Sanit; 1994; (8):10-1. PubMed ID: 7750748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug bioassay, synergy and quantitative structure activity relationships.
    Beezer AE
    Tokai J Exp Clin Med; 1990 Sep; 15(5):369-72. PubMed ID: 2131642
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.